INTERNATIONAL PATENT: SHANGHAI VITALGEN BIOPHARMA CO., LTD. FILES APPLICATION FOR "ENGINEERED MRNA FOR GENE EDITING USING CRISPR/CAS12B"

GENEVA, March 29 -- SHANGHAI VITALGEN BIOPHARMA CO., LTD. (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210) filed a patent application (PCT/CN2024/120028) for "ENGINEERED MRNA FOR GENE EDITING USING CRISPR/CAS12B" on Sep 20, 2024. With publication no. WO/2026/060637, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GUO, Lu (Building 3B, No.1 Yongtaizhuang North RoadHaidian District, Beijing 100192), ZHANG, Hongwei (Building 2, No.11 Jialilue RoadPudong New Area, Shanghai 201210), ZHU, Xi (Building 2, No.11 ...